Sareum Holdings (SAR)


Latest News

Sierra Oncology to host call on Chk1 inhibitor

RNS Number: 0247R Sareum Holdings PLC 18 September 2017 (AIM: SAR) 18 September 2017 SAREUM HOLDINGS PLC ("Sareum" or "the Company") Sierra Oncology to host Key Opinion Leader call with Thomas Helleday, PhD on DNA Damage Response Targets, on Tuesday 19 September Sareum Holdings plc (AIM: SAR) , the specialist cancer drug discovery an...

Sareum profit after tax anticipated to beat expectations

Sareum said it expects profit for the year after tax and cash at bank, for its results for the year to 30 June 2017, to be ahead...

Pre-Close Trading Statement

RNS Number: 5815O Sareum Holdings PLC 22 August 2017 (AIM: SAR) 22 August 2017 SAREUM HOLDINGS PLC ("Sareum" or "the Company") Pre-Close Trading Statement Sareum Holdings plc (AIM: SAR) , the specialist cancer drug discovery and development business, provides the following trading update ahead of its full year results for the year ending 30 Jun...

Sareum to Present at the ICCS 2017

RNS Number: 3717I Sareum Holdings PLC 19 June 2017 (AIM: SAR) Sareum Holdings PLC ("Sareum" or the "Company") Sareum to Present at the International Cancer Cluster Showcase 2017 Dr Tim Mitchell, CEO of Sareum Holdings plc (AIM:SAR), the specialist cancer drug discovery and development business, will deliver a presentation at the 6th annual Internatio...

All News

18-09-17Sierra Oncology to host call on Chk1 inhibitorRNS
22-08-17Sareum profit after tax anticipated to beat expectationsStockMarketWire
22-08-17Pre-Close Trading StatementRNS
19-06-17Sareum to Present at the ICCS 2017RNS
05-06-17Sareum updates on Chk1 inhibitor trialsStockMarketWire
05-06-17Chk1 Clinical Trials UpdateRNS
31-05-17Sareum Holdings notes Sierra Oncology patentsStockMarketWire
31-05-17Sierra Oncology Granted US and EU PatentsRNS
25-05-17Sierra Oncology to Present at ASCO Annual MeetingRNS
09-05-17Sareum to Present at BioTrinity 2017RNS
09-03-17Director Deals - Sareum Holdings PLC (SAR)StockMarketWire
09-03-17Director ShareholdingRNS
20-02-17Sareum swings to H1 pretax profitStockMarketWire
20-02-17Half-year ResultsRNS
09-02-17Notice of Interim ResultsRNS
09-01-17Milestone Payment from Chk1 Licence AgreementRNS
22-12-16Result of General MeetingRNS
15-12-16Result of AGMRNS
06-12-16Directors' Remuneration & General MeetingRNS
29-11-16Sareum to Present at AACR-NCI-EORTC ConferenceRNS
21-11-16Notice of AGMRNS
02-11-16Sareum Holdings narrows FY pretax lossStockMarketWire
02-11-16Final ResultsRNS
24-10-16Sareum says TYK2 feasibility study successfulStockMarketWire
24-10-16Successful Outcome from TYK2 Feasibility StudyRNS
17-10-16Sareum notes Japan, Singapore Patent GrantsStockMarketWire
17-10-16Japan and Singapore Patent GrantsRNS
27-09-16Banks keep FTSE in the red StockMarketWire
27-09-16Licence agreement for Chk1 Inhibitor CCT245737RNS
03-08-16Sareum confirms patent grants for Aurora+FLT3StockMarketWire
03-08-16China & HK Patent Grants for Sareum's Aurora+FLT3RNS
28-07-16Sareum comments on share-price moveStockMarketWire
28-07-16Movement in share priceRNS
23-05-16Clinical Trials CHK1 Inhibitor CCT245737 to OpenRNS
17-05-16Sareum appoints Stephen Parker as chairmanStockMarketWire
17-05-16Change of DirectorRNS
05-04-16FTSE falls on resources as Wall St, Europe dropStockMarketWire
05-04-16Should You Buy Blinkx Plc, Electrocomponents plc And Sareum Holdings Plc On Today’s News?Motley Fool
05-04-16Sareum's winStockMarketWire
05-04-16FTSE extends falls on resources; Europe tumblesStockMarketWire

RSS feeds

  • Editorial news feed for LSE:SAR Editorial
  • Regulatory news feed for LSE:SAR Regulatory